Novartis
NVS
NVS
1,267 hedge funds and large institutions have $15B invested in Novartis in 2023 Q4 according to their latest regulatory filings, with 136 funds opening new positions, 402 increasing their positions, 446 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,267
Holders Change
+46
Holders Change %
+3.77%
% of All Funds
18.57%
Holding in Top 10
14
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-12.5%
% of All Funds
0.21%
New
136
Increased
402
Reduced
446
Closed
69
Calls
$229M
Puts
$215M
Net Calls
+$14M
Net Calls Change
+$30.3M
Top Buyers
| 1 |
Morgan Stanley
New York
|
$1.43B |
| 2 |
MIP
Mondrian Investment Partners
London,
United Kingdom
|
$149M |
| 3 |
Goldman Sachs
New York
|
$357M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
$76.3M |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
$125M |
